Search results
Results listing
-
Novartis AG v Generics (UK) Ltd (t/a Mylan)
Court of Appeal (Civil Division)
[2012] EWCA Civ 1623
Matching text sample:
...SPC”) and its basic patent, UK Patent No. 2,203,040... ...to 9 of the basic patent were invalid.
The SPC and the patent are owned by the appellant...
...1 to 9 of the patent in order to market a... ...the process claims of the patent. The trial was therefore...
...upon in these proceedings, European Patent Application No. 0, 193...
-
Merck Sharp & Dohme Corporation v The Comptroller-General of Patents, Designs And Trade Marks
High Court (Patents Court)
[2016] EWHC 1896 (Pat)
Matching text sample:
The basic patent on which the Application relied... is European Patent (UK) No. 0... ...as Hypocholesterolemic Agents” (“the Patent”). This was filed... ...on 19 May 1999. The Patent protected both ezetimibe and combinations... ...by claim 17 of the Patent (which refers to atorvastatin... ...code CI-981). The Patent expired on 13 September 2014...
...a single day before the Patent expired. At that time...
...of an application for a patent for a new medicinal product... ...of effective protection under the patent insufficient to cover the investment...
...of a national or European patent relating to a medicinal product...
-
Sandoz AG & Ors v Bayer Intellectual Property GmbH & Ors
Court of Appeal (Civil Division)
[2024] EWCA Civ 562
Matching text sample:
...12 April 2024 revoking European Patent (UK) No. 1... 845 961 (“the Patent”) for the reasons given... ...alleged exclusive licensees of the Patent. The Respondents are various... ...order for revocation of the Patent and Bayer counterclaimed for threatened...
The Patent claims the use of rivaroxaban... ...were protected first by European Patent No. 1 261 606... ...If it is valid, the Patent prevents them from supplying generic... ...possible whether or not the Patent is valid, and for...
...the priority date of the Patent, 31 January 2005, were...
The title of the Patent is “Treatment of thromboembolic...
-
Newron Pharmaceuticals SpA v The Comptroller General of Patents, Trademarks and Designs
Court of Appeal (Civil Division)
[2024] EWCA Civ 128
Matching text sample:
...SPCs) are a form of patent term extension to compensate for... ...like. The normal 20 year patent term starts when the patent is applied for, once...
...two relevant documents – the patent and the marketing authorisation.... ...be granted is that the patent and the marketing authorisation must... ...product protected by the relevant patent. In this case the... ...the product protected by the patent.
The patent is EP (UK) 1... ...on 8 April 2004. The patent will expire on 7 April... ...2024. Claim 1 of the patent is in this form:
...product” protected by the relevant patent (see art 3(a)...
-
Teva UK Ltd & Anor v Leo Pharma A/s
High Court (Patents Court)
[2014] EWHC 3096 (Pat)
Matching text sample:
”. The 083 patent is a divisional of the... 808 patent. LEO contend that TEVA’... ...knowledge and a prior US patent 4,083,974 entitled “
...before the EPO. The 808 Patent has also been opposed by... ...20 October 2014. The 083 Patent was opposed by TEVA,...
The patent
The 808 patent explains that the invention concerns... ...pH values for stability. The patent acknowledges that it is common...
-
Autostore Technology AS v Ocado Group PLC & Ors.
High Court (Patents Court)
[2023] EWHC 716 (Pat)
Matching text sample:
...of “comprises” in a patent specification would allow for the...
...that this is what the patent means by the vehicle rolling...
...storage system of the 794 Patent is explicitly founded on the...
The patent attributes this space efficiency to...
-
Abbott & Anor v Design & Display Ltd & Anor
High Court (Intellectual Property Enterprise Court)
[2017] EWHC 932 (IPEC)
Matching text sample:
...found that Abbott’s European Patent (UK) No. 1... 816 931 (“the Patent”) was valid and had...
The Patent claimed a display panel of...
...the subject matter of the patent (often called ‘convoyed goods... ...the subject matter of the patent is incorporated. The court...
...Act an invention for a patent for which an application has... ...made or for which a patent has been granted shall,... ...specification of the application or patent, as the case may...
-
Genentech Inc. v The Comptroller General of Patents
Court of Appeal (Civil Division)
[2020] EWCA Civ 475
Matching text sample:
...extending the life of a patent for a medicinal product which...
...is granted before the basic patent is granted, the application... ...the date on which the patent is granted.
...lawful term of the basic patent for a period equal to... ...the application for a basic patent was lodged and the date...
the basic patent has lapsed before its lawful...
-
Nokia Technologies OY & Anor. v OnePlus Technology (Shenzhen) Co, Ltd & Ors.
Court of Appeal (Civil Division)
[2022] EWCA Civ 947
Matching text sample:
...5G telecommunications standards, including European Patent (UK) Nos. 2...
...patents) and England (one patent), although the Russian claim... ...June 2022 holding that European Patent (DE) No. 1...
...applications for SEPs). A patent is said to be standard... ...necessarily involve infringement of the patent in the absence of a...
...courts competent to adjudicate upon patent disputes.
-
Sandoz GmbH v Roche Diagnostics GmbH
High Court (Chancery Division)
[2004] EWHC 1313 (Ch)
Matching text sample:
...for the revocation of European Patent (UK) No 0,607... ,156. The patent teaches ways in which injectable... ...has applied to amend the patent in order to restrict the... ...the validity of the amended patent. Roche (through Mr Arnold... ...the validity of the amended patent no attempt would be made...
...in relation to the amended patent is whether the process set...
Obviousness over International Patent Application no. WO 91/...
...14 as amended of the patent in suit. For convenience... ...in this judgment to the Patent are to be read (... ...as references to the amended patent. It is accepted by...